Schneeberger Daniel
SEC CIK 1861120 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| KROS | Keros Therapeutics, Inc. | 10% | 0 | — | $95.66M | 2 | 2025-06-20 | 2025-10-15 |
Most active insiders at KROS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Schneeberger Daniel | 10% | — | $95.66M |
| 2 | Pontifax (China) IV L.P. | 10% | — | $84.98M |
| 3 | Cho Esther | SVP, GC | — | $123.7K |
| 4 | Seehra Jasbir | CEO, Dir | — | $113.4K |
| 5 | Lerner Lorena Raquel | CSO | — | $100.0K |
| 6 | Regnante Keith | CFO | — | $77.5K |
| 7 | BIENAIME JEAN JACQUES | Dir | $75.8K | — |
| 8 | Knowles Julius | Dir | — | $28.2K |
| 9 | Farzan Nima | Dir | — | $28.2K |
| 10 | Seth Alpna | Dir | — | $28.1K |
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2025-10-15 | 2025-10-15 | KROS | Keros Therapeutics, Inc. | Schneeberger Daniel | 10% | S - Sale | $17.75 | -5.39M | 0 | -100% | -$95.66M |
| DMI | 2025-06-24 | 2025-06-20 | KROS | Keros Therapeutics, Inc. | Schneeberger Daniel | 10% | X - OptEx | $69.41 | -1,700 | 743.4K | -0.2% | -$118.0K |
Purchase Sale Sale after option exercise All abbreviations